Complementary And Alternative Medicine During The COVID-19 Pandemic
Sponsor
Hasan Kalyoncu University (Other)
Overall Status
Completed
CT.gov ID
NCT04884321
Collaborator
Filiz Polat (Other), Aynur Ekren Çakıcı (Other)
3,242
1
1
3183.2
Study Details
Study Description
Brief Summary
Complementary and alternative medicine is frequently used in the treatment of several groups of diseases.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Detailed Description
This study aimed to explore the attitudes of adults living in Turkey toward complementary and alternative medicine in the period of the COVID-19 pandemic and identify whether Turkish adults used it during the pandemic.
Study Design
Study Type:
Observational
Actual Enrollment
:
3242 participants
Observational Model:
Other
Time Perspective:
Other
Official Title:
Adults' Attitudes Toward Complementary And Alternative Medicine And Their State Of Using Complementary And Alternative Medicine During The COVID-19 Pandemic
Actual Study Start Date
:
Feb 27, 2021
Actual Primary Completion Date
:
Mar 30, 2021
Actual Study Completion Date
:
Mar 30, 2021
Outcome Measures
Primary Outcome Measures
- Participant adults' responses to the questions raised about the use of complementary and alternative methods during the COVID-19 pandemic [2021]
- Means of scores obtained by participant adults from the holistic complementary and alternative medicine questionnaire (HCAMQ) and its sub-scales [2021]
Holistic Complementary and Alternative Medicine Questionnaire
- Complementary and alternative treatment methods used during the COVID-19 pandemic [2021]
- Plants consumed during the COVID-19 pandemic [2021]
- Symptoms against which complementary and alternative methods are used during the COVID-19 pandemic [2021]
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 65 Years
Sexes Eligible for Study:
All
Inclusion Criteria:
-
agree to participate in the study
-
not to be a communication problem
Exclusion Criteria:
- be a communication problem
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Hasan Kalyoncu Ünivrsitesi | Gaziantep | Lütfen Seç | Turkey | 27000 |
Sponsors and Collaborators
- Hasan Kalyoncu University
- Filiz Polat
- Aynur Ekren Çakıcı
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Leyla Delibas,
Assistant Professor,
Hasan Kalyoncu University
ClinicalTrials.gov Identifier:
NCT04884321
Other Study ID Numbers:
- HasanKUMYO
First Posted:
May 12, 2021
Last Update Posted:
May 12, 2021
Last Verified:
May 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Leyla Delibas,
Assistant Professor,
Hasan Kalyoncu University
Additional relevant MeSH terms: